Global Canine Vaccine market size is predicted to grow from US$ 1795 million in 2025 to US$ 2699 million in 2032; it is expected to grow at a CAGR of 6.1% from 2026 to 2032.

Global Canine Vaccine Market Growth and Outlook | CAGR of 6.1%

The global Canine Vaccine market size is predicted to grow from US$ 1795 million in 2025 to US$ 2699 million in 2032; it is expected to grow at a CAGR of 6.1% from 2026 to 2032. Canine vaccines can be divided into two categories: core vaccines and non-core vaccines. The so-called core vaccines are vaccines that are necessary for serious diseases with high infectiousness and high mortality rates, including rabies virus, distemper virus, canine adenovirus and canine parvovirus. Non-core vaccines can be evaluated based on the dogs living environment and physical condition to determine whether to vaccinate, including canine parainfluenza virus, leptospirosis, etc. United States market for Canine Vaccine is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032. China market for Canine Vaccine is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032. Europe market for Canine Vaccine is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032. Global key Canine Vaccine players cover Zoetis, Merck Animal Health, Pfizer, Boehringer Ingelheim, Virbac, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025. Infinity Market Research newest research report, the Canine Vaccine Industry Forecast looks at past sales and reviews total world Canine Vaccine sales in 2025, providing a comprehensive analysis by region and market sector of projected Canine Vaccine sales for 2026 through 2032. With Canine Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Canine Vaccine industry. This Insight Report provides a comprehensive analysis of the global Canine Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Canine Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms unique position in an accelerating global Canine Vaccine market. This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Canine Vaccine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Canine Vaccine. This report presents a comprehensive overview, market shares, and growth opportunities of Canine Vaccine market by product type, application, key manufacturers and key regions and countries. Segmentation by Type: &nbsp;&nbsp;&nbsp; Core Vaccines &nbsp;&nbsp;&nbsp; Non-Core Vaccines Segmentation by Application: &nbsp;&nbsp;&nbsp; Puppies &nbsp;&nbsp;&nbsp; Adult Dogs This report also splits the market by region: &nbsp;&nbsp;&nbsp; Americas &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; United States &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Canada &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Mexico &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Brazil &nbsp;&nbsp;&nbsp; APAC &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; China &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Japan &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Korea &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Southeast Asia &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; India &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Australia &nbsp;&nbsp;&nbsp; Europe &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Germany &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; France &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; UK &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Italy &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Russia &nbsp;&nbsp;&nbsp; Middle East & Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Egypt &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; South Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Israel &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Turkey &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; GCC Countries The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the companys coverage, product portfolio, its market penetration. &nbsp;&nbsp;&nbsp; Zoetis &nbsp;&nbsp;&nbsp; Merck Animal Health &nbsp;&nbsp;&nbsp; Pfizer &nbsp;&nbsp;&nbsp; Boehringer Ingelheim &nbsp;&nbsp;&nbsp; Virbac &nbsp;&nbsp;&nbsp; Durvet &nbsp;&nbsp;&nbsp; Elanco &nbsp;&nbsp;&nbsp; RuiPu Bio-Technology &nbsp;&nbsp;&nbsp; CAHIC &nbsp;&nbsp;&nbsp; Wuhan Keqian Biology &nbsp;&nbsp;&nbsp; Jilin Five-Star Animal Health &nbsp;&nbsp;&nbsp; NeoTech &nbsp;&nbsp;&nbsp; JINHE &nbsp;&nbsp;&nbsp; SINOVAC &nbsp;&nbsp;&nbsp; Biogenesis Bago Key Questions Addressed in this Report What is the 10-year outlook for the global Canine Vaccine market? What factors are driving Canine Vaccine market growth, globally and by region? Which technologies are poised for the fastest growth by market and region? How do Canine Vaccine market opportunities vary by end market size? How does Canine Vaccine break out by Type, by Application?

1 Scope of the Report &nbsp;1.1 Market Introduction &nbsp;1.2 Years Considered &nbsp;1.3 Research Objectives &nbsp;1.4 Market Research Methodology &nbsp;1.5 Research Process and Data Source &nbsp;1.6 Economic Indicators &nbsp;1.7 Currency Considered &nbsp;1.8 Market Estimation Caveats 2 Executive Summary &nbsp;2.1 World Market Overview &nbsp;2.1.1 Global Canine Vaccine Annual Sales 2021-2032 &nbsp;2.1.2 World Current & Future Analysis for Canine Vaccine by Geographic Region, 2021, 2025 & 2032 &nbsp;2.1.3 World Current & Future Analysis for Canine Vaccine by Country/Region, 2021, 2025 & 2032 &nbsp;2.2 Canine Vaccine Segment by Type &nbsp;2.2.1 Core Vaccines &nbsp;2.2.2 Non-Core Vaccines &nbsp;2.2.3 Canine Vaccine Sales by Type &nbsp;2.2.3.1 Global Canine Vaccine Sales Market Share by Type (2021-2026) &nbsp;2.2.3.2 Global Canine Vaccine Revenue and Market Share by Type (2021-2026) &nbsp;2.2.3.3 Global Canine Vaccine Sale Price by Type (2021-2026) &nbsp;2.3 Canine Vaccine Segment by Application &nbsp;2.3.1 Puppies &nbsp;2.3.2 Adult Dogs &nbsp;2.3.3 Canine Vaccine Sales by Application &nbsp;2.3.3.1 Global Canine Vaccine Sale Market Share by Application (2021-2026) &nbsp;2.3.3.2 Global Canine Vaccine Revenue and Market Share by Application (2021-2026) &nbsp;2.3.3.3 Global Canine Vaccine Sale Price by Application (2021-2026) 3 Global by Company &nbsp;3.1 Global Canine Vaccine Breakdown Data by Company &nbsp;3.1.1 Global Canine Vaccine Annual Sales by Company (2021-2026) &nbsp;3.1.2 Global Canine Vaccine Sales Market Share by Company (2021-2026) &nbsp;3.2 Global Canine Vaccine Annual Revenue by Company (2021-2026) &nbsp;3.2.1 Global Canine Vaccine Revenue by Company (2021-2026) &nbsp;3.2.2 Global Canine Vaccine Revenue Market Share by Company (2021-2026) &nbsp;3.3 Global Canine Vaccine Sale Price by Company &nbsp;3.4 Key Manufacturers Canine Vaccine Producing Area Distribution, Sales Area, Product Type &nbsp;3.4.1 Key Manufacturers Canine Vaccine Product Location Distribution &nbsp;3.4.2 Players Canine Vaccine Products Offered &nbsp;3.5 Market Concentration Rate Analysis &nbsp;3.5.1 Competition Landscape Analysis &nbsp;3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026) &nbsp;3.6 New Products and Potential Entrants &nbsp;3.7 Market M&A Activity & Strategy 4 World Historic Review for Canine Vaccine by Geographic Region &nbsp;4.1 World Historic Canine Vaccine Market Size by Geographic Region (2021-2026) &nbsp;4.1.1 Global Canine Vaccine Annual Sales by Geographic Region (2021-2026) &nbsp;4.1.2 Global Canine Vaccine Annual Revenue by Geographic Region (2021-2026) &nbsp;4.2 World Historic Canine Vaccine Market Size by Country/Region (2021-2026) &nbsp;4.2.1 Global Canine Vaccine Annual Sales by Country/Region (2021-2026) &nbsp;4.2.2 Global Canine Vaccine Annual Revenue by Country/Region (2021-2026) &nbsp;4.3 Americas Canine Vaccine Sales Growth &nbsp;4.4 APAC Canine Vaccine Sales Growth &nbsp;4.5 Europe Canine Vaccine Sales Growth &nbsp;4.6 Middle East & Africa Canine Vaccine Sales Growth 5 Americas &nbsp;5.1 Americas Canine Vaccine Sales by Country &nbsp;5.1.1 Americas Canine Vaccine Sales by Country (2021-2026) &nbsp;5.1.2 Americas Canine Vaccine Revenue by Country (2021-2026) &nbsp;5.2 Americas Canine Vaccine Sales by Type (2021-2026) &nbsp;5.3 Americas Canine Vaccine Sales by Application (2021-2026) &nbsp;5.4 United States &nbsp;5.5 Canada &nbsp;5.6 Mexico &nbsp;5.7 Brazil 6 APAC &nbsp;6.1 APAC Canine Vaccine Sales by Region &nbsp;6.1.1 APAC Canine Vaccine Sales by Region (2021-2026) &nbsp;6.1.2 APAC Canine Vaccine Revenue by Region (2021-2026) &nbsp;6.2 APAC Canine Vaccine Sales by Type (2021-2026) &nbsp;6.3 APAC Canine Vaccine Sales by Application (2021-2026) &nbsp;6.4 China &nbsp;6.5 Japan &nbsp;6.6 South Korea &nbsp;6.7 Southeast Asia &nbsp;6.8 India &nbsp;6.9 Australia &nbsp;6.10 China Taiwan 7 Europe &nbsp;7.1 Europe Canine Vaccine by Country &nbsp;7.1.1 Europe Canine Vaccine Sales by Country (2021-2026) &nbsp;7.1.2 Europe Canine Vaccine Revenue by Country (2021-2026) &nbsp;7.2 Europe Canine Vaccine Sales by Type (2021-2026) &nbsp;7.3 Europe Canine Vaccine Sales by Application (2021-2026) &nbsp;7.4 Germany &nbsp;7.5 France &nbsp;7.6 UK &nbsp;7.7 Italy &nbsp;7.8 Russia 8 Middle East & Africa &nbsp;8.1 Middle East & Africa Canine Vaccine by Country &nbsp;8.1.1 Middle East & Africa Canine Vaccine Sales by Country (2021-2026) &nbsp;8.1.2 Middle East & Africa Canine Vaccine Revenue by Country (2021-2026) &nbsp;8.2 Middle East & Africa Canine Vaccine Sales by Type (2021-2026) &nbsp;8.3 Middle East & Africa Canine Vaccine Sales by Application (2021-2026) &nbsp;8.4 Egypt &nbsp;8.5 South Africa &nbsp;8.6 Israel &nbsp;8.7 Turkey &nbsp;8.8 GCC Countries 9 Market Drivers, Challenges and Trends &nbsp;9.1 Market Drivers & Growth Opportunities &nbsp;9.2 Market Challenges & Risks &nbsp;9.3 Industry Trends 10 Manufacturing Cost Structure Analysis &nbsp;10.1 Raw Material and Suppliers &nbsp;10.2 Manufacturing Cost Structure Analysis of Canine Vaccine &nbsp;10.3 Manufacturing Process Analysis of Canine Vaccine &nbsp;10.4 Industry Chain Structure of Canine Vaccine 11 Marketing, Distributors and Customer &nbsp;11.1 Sales Channel &nbsp;11.1.1 Direct Channels &nbsp;11.1.2 Indirect Channels &nbsp;11.2 Canine Vaccine Distributors &nbsp;11.3 Canine Vaccine Customer 12 World Forecast Review for Canine Vaccine by Geographic Region &nbsp;12.1 Global Canine Vaccine Market Size Forecast by Region &nbsp;12.1.1 Global Canine Vaccine Forecast by Region (2027-2032) &nbsp;12.1.2 Global Canine Vaccine Annual Revenue Forecast by Region (2027-2032) &nbsp;12.2 Americas Forecast by Country (2027-2032) &nbsp;12.3 APAC Forecast by Region (2027-2032) &nbsp;12.4 Europe Forecast by Country (2027-2032) &nbsp;12.5 Middle East & Africa Forecast by Country (2027-2032) &nbsp;12.6 Global Canine Vaccine Forecast by Type (2027-2032) &nbsp;12.7 Global Canine Vaccine Forecast by Application (2027-2032) 13 Key Players Analysis &nbsp;13.1 Zoetis &nbsp;13.1.1 Zoetis Company Information &nbsp;13.1.2 Zoetis Canine Vaccine Product Portfolios and Specifications &nbsp;13.1.3 Zoetis Canine Vaccine Sales, Revenue, Price and Gross Margin (2021-2026) &nbsp;13.1.4 Zoetis Main Business Overview &nbsp;13.1.5 Zoetis Latest Developments &nbsp;13.2 Merck Animal Health &nbsp;13.2.1 Merck Animal Health Company Information &nbsp;13.2.2 Merck Animal Health Canine Vaccine Product Portfolios and Specifications &nbsp;13.2.3 Merck Animal Health Canine Vaccine Sales, Revenue, Price and Gross Margin (2021-2026) &nbsp;13.2.4 Merck Animal Health Main Business Overview &nbsp;13.2.5 Merck Animal Health Latest Developments &nbsp;13.3 Pfizer &nbsp;13.3.1 Pfizer Company Information &nbsp;13.3.2 Pfizer Canine Vaccine Product Portfolios and Specifications &nbsp;13.3.3 Pfizer Canine Vaccine Sales, Revenue, Price and Gross Margin (2021-2026) &nbsp;13.3.4 Pfizer Main Business Overview &nbsp;13.3.5 Pfizer Latest Developments &nbsp;13.4 Boehringer Ingelheim &nbsp;13.4.1 Boehringer Ingelheim Company Information &nbsp;13.4.2 Boehringer Ingelheim Canine Vaccine Product Portfolios and Specifications &nbsp;13.4.3 Boehringer Ingelheim Canine Vaccine Sales, Revenue, Price and Gross Margin (2021-2026) &nbsp;13.4.4 Boehringer Ingelheim Main Business Overview &nbsp;13.4.5 Boehringer Ingelheim Latest Developments &nbsp;13.5 Virbac &nbsp;13.5.1 Virbac Company Information &nbsp;13.5.2 Virbac Canine Vaccine Product Portfolios and Specifications &nbsp;13.5.3 Virbac Canine Vaccine Sales, Revenue, Price and Gross Margin (2021-2026) &nbsp;13.5.4 Virbac Main Business Overview &nbsp;13.5.5 Virbac Latest Developments &nbsp;13.6 Durvet &nbsp;13.6.1 Durvet Company Information &nbsp;13.6.2 Durvet Canine Vaccine Product Portfolios and Specifications &nbsp;13.6.3 Durvet Canine Vaccine Sales, Revenue, Price and Gross Margin (2021-2026) &nbsp;13.6.4 Durvet Main Business Overview &nbsp;13.6.5 Durvet Latest Developments &nbsp;13.7 Elanco &nbsp;13.7.1 Elanco Company Information &nbsp;13.7.2 Elanco Canine Vaccine Product Portfolios and Specifications &nbsp;13.7.3 Elanco Canine Vaccine Sales, Revenue, Price and Gross Margin (2021-2026) &nbsp;13.7.4 Elanco Main Business Overview &nbsp;13.7.5 Elanco Latest Developments &nbsp;13.8 RuiPu Bio-Technology &nbsp;13.8.1 RuiPu Bio-Technology Company Information &nbsp;13.8.2 RuiPu Bio-Technology Canine Vaccine Product Portfolios and Specifications &nbsp;13.8.3 RuiPu Bio-Technology Canine Vaccine Sales, Revenue, Price and Gross Margin (2021-2026) &nbsp;13.8.4 RuiPu Bio-Technology Main Business Overview &nbsp;13.8.5 RuiPu Bio-Technology Latest Developments &nbsp;13.9 CAHIC &nbsp;13.9.1 CAHIC Company Information &nbsp;13.9.2 CAHIC Canine Vaccine Product Portfolios and Specifications &nbsp;13.9.3 CAHIC Canine Vaccine Sales, Revenue, Price and Gross Margin (2021-2026) &nbsp;13.9.4 CAHIC Main Business Overview &nbsp;13.9.5 CAHIC Latest Developments &nbsp;13.10 Wuhan Keqian Biology &nbsp;13.10.1 Wuhan Keqian Biology Company Information &nbsp;13.10.2 Wuhan Keqian Biology Canine Vaccine Product Portfolios and Specifications &nbsp;13.10.3 Wuhan Keqian Biology Canine Vaccine Sales, Revenue, Price and Gross Margin (2021-2026) &nbsp;13.10.4 Wuhan Keqian Biology Main Business Overview &nbsp;13.10.5 Wuhan Keqian Biology Latest Developments &nbsp;13.11 Jilin Five-Star Animal Health &nbsp;13.11.1 Jilin Five-Star Animal Health Company Information &nbsp;13.11.2 Jilin Five-Star Animal Health Canine Vaccine Product Portfolios and Specifications &nbsp;13.11.3 Jilin Five-Star Animal Health Canine Vaccine Sales, Revenue, Price and Gross Margin (2021-2026) &nbsp;13.11.4 Jilin Five-Star Animal Health Main Business Overview &nbsp;13.11.5 Jilin Five-Star Animal Health Latest Developments &nbsp;13.12 NeoTech &nbsp;13.12.1 NeoTech Company Information &nbsp;13.12.2 NeoTech Canine Vaccine Product Portfolios and Specifications &nbsp;13.12.3 NeoTech Canine Vaccine Sales, Revenue, Price and Gross Margin (2021-2026) &nbsp;13.12.4 NeoTech Main Business Overview &nbsp;13.12.5 NeoTech Latest Developments &nbsp;13.13 JINHE &nbsp;13.13.1 JINHE Company Information &nbsp;13.13.2 JINHE Canine Vaccine Product Portfolios and Specifications &nbsp;13.13.3 JINHE Canine Vaccine Sales, Revenue, Price and Gross Margin (2021-2026) &nbsp;13.13.4 JINHE Main Business Overview &nbsp;13.13.5 JINHE Latest Developments &nbsp;13.14 SINOVAC &nbsp;13.14.1 SINOVAC Company Information &nbsp;13.14.2 SINOVAC Canine Vaccine Product Portfolios and Specifications &nbsp;13.14.3 SINOVAC Canine Vaccine Sales, Revenue, Price and Gross Margin (2021-2026) &nbsp;13.14.4 SINOVAC Main Business Overview &nbsp;13.14.5 SINOVAC Latest Developments &nbsp;13.15 Biogenesis Bago &nbsp;13.15.1 Biogenesis Bago Company Information &nbsp;13.15.2 Biogenesis Bago Canine Vaccine Product Portfolios and Specifications &nbsp;13.15.3 Biogenesis Bago Canine Vaccine Sales, Revenue, Price and Gross Margin (2021-2026) &nbsp;13.15.4 Biogenesis Bago Main Business Overview &nbsp;13.15.5 Biogenesis Bago Latest Developments 14 Research Findings and Conclusion

Report	Global Canine Vaccine Market Trends, Growth and Outlook 2026-2032
Selected License	Multi ID: ILR3357

Buyer Information

Order Summary